ECP
INVA icon

Empyrean Capital Partners’s Innoviva INVA Stock Holding History

Empyrean Capital Partners’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-975,005
Closed -$13.8M – 68
2017
Q3 		$13.8M Sell
975,005
-1,022,914
-51% -$13.5M 0.53% 36
2017
Q2 		$25.6M Sell
1,997,919
-180,896
-8% -$2.27M 1.09% 26
2017
Q1 		$30.1M Sell
2,178,815
-60,500
-3% -$712K 1.34% 21
2016
Q4 		$24M Hold
2,239,315
– – 0.9% 23
2016
Q3 		$24.6M Sell
2,239,315
-1,106,251
-33% -$12.9M 1.24% 23
2016
Q2 		$35.2M Sell
3,345,566
-319,192
-9% -$3.78M 1.59% 21
2016
Q1 		$46.1M Buy
3,664,758
+125,900
+4% +$1.38M 1.93% 19
2015
Q4 		$37.3M Buy
3,538,858
+796,556
+29% +$7.33M 1.38% 27
2015
Q3 		$19.7M Buy
2,742,302
+629,410
+30% +$8.55M 0.97% 29
2015
Q2 		$38.2M Buy
2,112,892
+312,892
+17% +$5.37M 1.78% 23
2015
Q1 		$28.3M Buy
1,800,000
+120,111
+7% +$1.82M 1.41% 24
2014
Q4 		$23.8M Buy
+1,679,889
New +$25.2M 1.35% 22

Other funds holding INVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Empyrean Capital Partners's INVA Position: Q4 2017 in Review

Empyrean Capital Partners sold out of Innoviva (INVA) in Q4 2017, closing a stake of 975,005 shares — an estimated $13.8M sold.

Empyrean Capital Partners first reported a position in INVA in Q4 2014 and held it in 12 quarters. The position peaked at $46.1M in Q1 2016. 200 funds tracked by Wall St. Rank hold INVA as of Q4 2017.

  • Empyrean Capital Partners reported no remaining Innoviva position as of Q4 2017 after selling out during the quarter.
  • Empyrean Capital Partners sold 975,005 Innoviva shares in Q4 2017, an estimated $13.8M.
  • Empyrean Capital Partners first reported a position in Innoviva in Q4 2014 and held it in 12 quarters.
  • Empyrean Capital Partners's Innoviva position peaked at $46.1M in Q1 2016.
  • 200 funds tracked by Wall St. Rank held Innoviva as of Q4 2017.

Based on Empyrean Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.